cardiovascular diseases

Hsu JJ, Li Q, Tintut Y, Demer LL. Considerations in the Use of Mouse Models of Vascular and Valvular Calcification. Arterioscler Thromb Vasc Biol. 2026[...]

By afschroeder • March 7, 2026

Gupta N, Liu Y, Cai B. Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications. Immunohorizons. 2026 Feb 17;10(SI):vlag002. doi: 10.1093/immhor/vlag002. PMID: 41774843; PMCID: PMC12955849.

By afschroeder • March 4, 2026

Marnell CS, Koenig W, Bittner V, Watson KE, Muntner P, Nordestgaard BG, Yan LL, Verbakel M, Rosenson RS. Barriers and Emerging Strategies to Bridge Gaps[...]

By afschroeder • March 2, 2026

Karpouzas GA, Pascual-Ramos V, Gonzalez-Gay MA, Misra DP, Myasoedova E, Rantapää-Dahlqvist S, Sfikakis P, Dessein P, Hitchon CA, Galarza-Delgado D, Van Riel P, Semb AG,[...]

By afschroeder • February 3, 2026

Abel ED, Ahima RS, Anderson EJ, Berg DD, Berger JS, Das S, Feinberg MW, Fisher EA, Garshick MS, Giannarelli C, Goldberg IJ, Hamburg NM, Kim[...]

By afschroeder • January 16, 2026

Nguyen T, Chang CE, Tao R, Liu K, Zhang ZF, Hashibe M. Risk of incident cardiovascular disease events among older Asian, Native Hawaiian, and Pacific[...]

By afschroeder • January 12, 2026

Karpouzas GA, Papotti B, Ormseth SR, Palumbo M, Hernandez E, Budoff MJ, Ronda N. Sex and reproductive stage modify the effect of endogenous oestrogens on[...]

By afschroeder • December 9, 2025

Xue L, Bhattacharya R, Uddin MM, Nakao T, Zou R, Patel A, Haidermota S, Niroula A, Viscosi V, Postupaka D, Bhatnagar A, Finneran P, Bernardo[...]

By afschroeder • November 6, 2025

Kawai K, Muhere CF, Lemos EV, Francis JM. Viral Infections and Risk of Cardiovascular Disease: Systematic Review and Meta-Analysis. J Am Heart Assoc. 2025 Oct[...]

By afschroeder • October 30, 2025

Bolles M, Alger HM, Elkind MSV, Haft H, Lewsey SC, Jessup M, Joynt Maddox KE, Ndumele CE, Yancy CW, Rutan C, Congdon M, Overton K,[...]

By afschroeder • October 21, 2025